Skip to content

Clinical trials

Phase 3 Stroke trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: New Zealand Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20071
20081
20091
20101
20111
20132
20141
20151
20171
20181
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated4
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
AstraZeneca1
Boehringer Ingelheim1
CSL Behring1
Daiichi Sankyo1
Eli Lilly and Company1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Neurobiological Technologies1
Neuroscience Trials Australia1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke15
Atrial Fibrillation4
Cardiovascular Diseases3
Ischemic Stroke3
Myocardial Infarction3
Acute Coronary Syndrome2
Embolism2
Heart Diseases2
Hyperlipidemias2
Arrhythmias, Cardiac1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.